Ken Griffin Codexis, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Codexis, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 7,900 shares of CDXS stock, worth $32,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,900

Previous 7,600 3.95%

Holding current value

$32,073

Previous $26,000 7.69%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.65 - $3.92 $284,095 - $420,247	-107,206 Reduced 30.5%	244,340 $757,000
Q1 2024 May 15, 2024	BUY	$2.59 - $4.65 $580,038 - $1.04 Million	223,953 Added 175.52%	351,546 $1.23 Million
Q4 2023 Feb 14, 2024	BUY	$1.54 - $3.37 $32,118 - $70,284	20,856 Added 19.54%	127,593 $389,000
Q3 2023 Nov 14, 2023	SELL	$1.5 - $3.75 $228,436 - $571,091	-152,291 Reduced 58.79%	106,737 $201,000
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.43 $1.88 Million - $3.78 Million	-852,821 Reduced 76.7%	259,028 $725,000
Q1 2023 May 15, 2023	BUY	$3.81 - $6.76 $579,687 - $1.03 Million	152,149 Added 15.85%	1,111,849 $4.6 Million
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $732,426 - $1.18 Million	171,931 Added 21.83%	959,700 $4.47 Million
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $3.33 Million - $7.06 Million	548,840 Added 229.71%	787,769 $4.77 Million
Q2 2022 Aug 15, 2022	SELL	$8.35 - $21.89 $383,123 - $1 Million	-45,883 Reduced 16.11%	238,929 $2.5 Million
Q1 2022 May 16, 2022	SELL	$16.97 - $31.93 $8.74 Million - $16.4 Million	-514,885 Reduced 64.39%	284,812 $5.87 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $41.78 $10.5 Million - $17.2 Million	411,342 Added 105.92%	799,697 $25 Million
Q3 2021 Nov 15, 2021	BUY	$19.65 - $27.99 $1.81 Million - $2.58 Million	92,169 Added 31.12%	388,355 $9.03 Million
Q2 2021 Aug 16, 2021	BUY	$17.48 - $25.46 $981,641 - $1.43 Million	56,158 Added 23.4%	296,186 $6.71 Million
Q1 2021 May 17, 2021	BUY	$18.08 - $28.8 $2.85 Million - $4.54 Million	157,633 Added 191.31%	240,028 $5.49 Million
Q4 2020 Feb 16, 2021	BUY	$11.7 - $23.41 $496,840 - $994,105	42,465 Added 106.35%	82,395 $1.8 Million
Q3 2020 Nov 16, 2020	SELL	$11.21 - $13.82 $134,632 - $165,978	-12,010 Reduced 23.12%	39,930 $469,000
Q2 2020 Aug 14, 2020	BUY	$9.8 - $12.77 $311,885 - $406,405	31,825 Added 158.22%	51,940 $592,000
Q1 2020 May 15, 2020	BUY	$8.78 - $18.6 $59,826 - $126,740	6,814 Added 51.23%	20,115 $225,000
Q4 2019 Feb 14, 2020	BUY	$13.12 - $17.06 $31,081 - $40,415	2,369 Added 21.67%	13,301 $213,000
Q2 2019 Aug 14, 2019	SELL	$17.0 - $21.88 $26,775 - $34,461	-1,575 Reduced 12.59%	10,932 $201,000
Q1 2018 May 11, 2018	BUY	$8.0 - $12.8 $100,056 - $160,089	12,507 New	12,507 $138,000

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

47.9M

Call Options Held

33.7K

Put Options Held

20.2K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $266M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account